Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical De…
Medical - Devices
US, North Chicago [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | 87.23 | 139.78 | 74.65 | |
| Graham Fair Price | -12.10 | 18.86 | 21.46 | |
| PEG | -37.05 | -1.74 | 2.76 | |
| Price/Book | 1.29 | 5.01 | 4.94 | |
| Price/Cash Flow | 270.80 | 310.00 | 83.60 | |
| Prices/Earnings | 32.51 | 39.67 | 29.94 | |
| Price/Sales | 4.67 | 19.51 | 18.64 | |
| Price/FCF | 270.80 | 310.00 | 83.60 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Weak
Fundamentals
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | 8.37 | 0.56 | 0.51 | |
| Operating Margin | -20.05 | 0.15 | 0.18 | |
| ROA | -22.36 | 0.02 | 0.02 | |
| ROE | 0.04 | 0.03 | -23.56 | |
| ROIC | 0.03 | 0.02 | -25.09 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | -0.08 | 0.02 | 264.94 | |
| Dividends QOQ | < 0.005 | 0.08 | 2814.21 | |
| EBIT QOQ | 0.05 | -0.22 | 313.58 | |
| EPS QOQ | 0.11 | -0.23 | 110.51 | |
| FCF QOQ | 0.73 | -0.73 | -1.11 | |
| Revenue QOQ | < 0.005 | -0.03 | 179.95 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Positive
Fundamentals
Leverage & Liquidity
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 118.66 | 139.01 | 17.15 | |
| Days Sales Outstanding (DSO) | 57.69 | 59.66 | 3.41 | |
| Inventory Turnover | 0.76 | 0.65 | -14.64 | |
| Debt/Capitalization | 0.28 | 0.27 | -2.03 | |
| Quick Ratio | 1.00 | 0.95 | -5.48 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Bad
Fundamentals
Per Share Metrics
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 22.26 | 22.38 | 0.54 | |
| Cash | 4.20 | 3.84 | -8.63 | |
| Capex | -0.44 | -0.23 | 47.28 | |
| Free Cash Flow | 1.32 | 0.36 | -72.54 | |
| Revenue | 5.91 | 5.75 | -2.70 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Bad
Fundamentals
Financial Health
06 - Financial Health ·
Weak